New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2013
07:48 EDTPTXPernix Therapeutics shares could rebound on good execution, says Stifel
After Pernix reported much lower than expected Q1 revenue, Stifel lowered its price target on the stock to $4 from $10 but keeps a Buy rating on the shares based on valuation.
News For PTX From The Last 14 Days
Check below for free stories on PTX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 20, 2014
08:30 EDTPTXPernix closes acquisition of Treximet
Subscribe for More Information
08:29 EDTPTXPernix Therapeutics to host conference call
Conference call to discuss acquisition of Treximet will be held on August 20 at 9 am. Webcast Link
08:24 EDTPTXPernix Therapeutics management to meet with Needham
Subscribe for More Information
08:08 EDTPTXPernix sees FY15 revenue approximately $230M, consensus $214.07M
Sees FY15 adjusted EBITDA $95M.
08:07 EDTPTXPernix Therapeutics sees FY14 revenue $110M-$120M, consensus $116.87M
Subscribe for More Information
08:04 EDTPTXPOZEN announces U.S. rights for Treximet acquired by Pernix Therapeutics
Subscribe for More Information
August 11, 2014
08:37 EDTPTXPernix says closing of deal to acquire U.S. rights to Treximet delayed
Subscribe for More Information
08:34 EDTPTXPernix Therapeutics reports Q2 EPS (16c), two estimates (5c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use